Post-transcriptional Control of Tumor Cell Autonomous Metastatic Potential by CCR4-NOT Deadenylase CNOT7

Farhoud Faraji1,2, Ying Hu3, Howard H Yang1

  • 1Metastasis Susceptibility Section, Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.

Plos Genetics
|January 26, 2016
PubMed

Insights

The CCR4-NOT complex subunit Cnot7 promotes cancer metastasis by regulating RNA stability. Its deadenylase activity, along with interactions with CNOT1 and TOB1, controls gene expression to drive tumor cell spread.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Transcriptional Regulation

Background:

  • Aberrant transcriptomes drive cancer metastasis.
  • Deadenylation regulates RNA stability and microRNA control.
  • CCR4-NOT complex subunit Cnot2 is a known metastasis susceptibility gene.

Purpose of the Study:

  • To investigate the role of Cnot7, an enzymatic subunit of the CCR4-NOT complex, in cancer metastasis.
  • To determine the mechanism by which Cnot7 influences metastatic potential.

Main Methods:

  • Orthotopic metastasis assays in mouse models.
  • Genetically engineered mouse models.
  • Ribonucleoprotein-immunoprecipitation (RIP) followed by transcriptome-wide analyses.

Main Results:

  • Cnot7 expression promotes tumor cell-autonomous metastatic potential, dependent on its deadenylase activity.
  • CNOT7-mediated metastasis promotion requires interaction with CNOT1 and TOB1.
  • CNOT7-regulated transcripts are enriched for specific 3'UTR motifs involved in RNA-binding protein complexes.

Conclusions:

  • CNOT7 acts as a metastasis-modifying gene.
  • CNOT7, TOB1, CNOT1, and associated RNA-binding proteins cooperatively control a metastasis-suppressive program via post-transcriptional regulation.
  • This coordinated action drives tumor cell metastasis.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K